Influence of albendazole on the disposition kinetics and milk antimicrobial equivalent activity of enrofloxacin in lactating goats

Pharmacological Research

Volumn 48, Issue 4, 2003, Pages 389-395

  Abo El Sooud, K ^a  

^a Cairo University   (Egypt)

Author keywords

Albendazole; Enrofloxacin; Goats; Interactions; Milk; Pharmacokinetic

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTIINFECTIVE AGENT; AVITRYL 5; ENROFLOXACIN; VERMIZOLE;

ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MILK LEVEL; FEMALE; GOAT; LACTATION; MEAN RESIDENCE TIME; MICROBIOLOGY; MILK; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0041666490     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00179-8     Document Type: Article

References (38)

1. Gillum J.G., Israel D.S., Polk R.E. Pharmacokinetic drug interactions with antimicrobial agents. Clin. Pharmacokinet. 25:1993;450-482.
2. Prescott J.F., Yielding K.M. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin, and norfloxacin. Can J. Vet. Res. 54:1990;195-197.
3. Brown S.A. Fluoroquinolones in animal health. J. Vet. Pharmacol. Ther. 19:1996;1-14.
4. Butaye P., Ducatelle R., De-Backer P. In vitro activities of doxycycline and enrofloxacin against European Chlamydia psittaci strains from turkeys. Antimicrob. Agents Chemother. 41:1997;2800-2801.
5. Pellerin J.L., Bourdeau P., Sebbag H. Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedius clinical isolates from canine pyodermas. Comp. Immunol. Microbial Infect. Dis. 21:1998;115-133.
6. Sumano L.H., Ocampo C.L., Brumbaugh G.W. Effectiveness of two fluoroquinolones for the treatment of chronic respiratory disease outbreak in broilers. Br. Poult. Sci. 39:1998;42-46.
7. Schroder J. Enrofloxacin: a new antimicrobial agent. J.S. Afr. Vet. Assoc. 60:1989;122-124.
8. Dorfman M., Barsanti J., Budsberg S.C. Enrofloxacin concentrations in dogs with normal prostate and dogs with chronic bacterial prostatitis. Am. J. Vet. Res. 56:1995;386-390.
9. Kaartinen L., Pyorala S., Moilanen M., Raisanen S. Pharmacokinetics of enrofloxacin in newborn and one-week-old calves. J. Vet. Pharmacol. Ther. 20:1997;479-482.
10. Bregante M.A., Saez P., Aramayona J.J., Fraile L., Garcia M.A., Solans C. Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows. Am. J. Vet. Res. 60:1999;1111-1116.
11. Kung K., Riond J.L., Wanner M. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. J. Vet. Pharmacol. Ther. 16:1993;462-468.
12. Haines G.R., Brown M.P., Gronwall R.R., Merritt K.A. Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares. Can J. Vet. Res. 64:2000;171-177.
13. Mengozzi G., Intorre L., Bertini S., Soldani G. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep. Am. J. Vet. Res. 57:1996;1040-1043.
14. Gavrielli R., Yagil R., Ziv G., Creveld C.V., Glickman A. Effect of water deprivation on the disposition kinetics of enrofloxacin in camels. J. Vet. Pharmacol. Ther. 18:1995;333-339.
15. Broome R.L., Brooks D.L., Babish J.G., Copeland D.D., Conzelman G.M. Pharmacokinetics properties of enrofloxacin in rabbits. Am. J. Vet. Res. 52:1991;1835-1841.
16. Anadon A., Martinez-Larranaga M.R., Diaz M.J., Bringas P., Martinez M.A., Fernandez-Cruz M.L.et al. Pharmacokinetics and residues of enrofloxacin in chickens. Am. J. Vet. Res. 56:1995;501-506.
17. Elmas M., Tras B., Kaya S., Bas A.L., Yazar E., Yarsan E. Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in Angora goats. Can J. Vet. Res. 65(1):2001;64-67.
18. Rao G.S., Ramesh S., Ahmad A.H., Tripathi H.C., Sharma L.D., Malik J.K. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intramuscular administration of enrofloxacin in goats. Vet. Res. Commun. 25(3):2001;197-204.
19. Yoshimura H., Ishimaru M., Endoh Y.S., Kojima A. Antimicrobial susceptibility of Pasteurella multocida isolated from cattle and pigs. J. Vet. Med. B. 48:2001;555-560.
20. Salmon S.A., Watts J.L., Aarestrualmon F.M., Watts J.L., Aarestru F.M. Minimum inhibitory concentrations for selected antimicrobial agents against organisms isolated from the mammary glands of dairy heifers in New Zealand and Denmark. J. Dairy Sci. 81:1998;570-578.
21. Campbell W. Benzimedazole: veterinary uses. Parasitol. Today. 6:1990;130-133.
22. Alvarez L.I., Sanchez S.F., Lanusse C.E. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep. J. Vet. Pharmacol. Ther. 22:1999;77-86.
23. Foreyt W.J. Efficacy and safety of albendazole against experimentally induced Fasciola hepatica infections in goats. Vet. Parasitol. 26:1988;261-264.
24. Escobar-Garcia D., Camacho-Carranza R., Perez I., Dorado V., Arriaga-Alba M., Espinosa-Aguirre J.J. S9 induction by the combined treatment with cyclohexanol and albendazole. Mutagenesis. 16(6):2001;523-528.
25. Bennett J.V., Brodie J.L., Benner E.J., Kirby W.M.M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl. Microbiol. 14:1966;170-177.
26. Craig AW, Suh B. Protein binding and the antibacterial effects: methods for determination of protein binding. In: Lorian V, editor. Antibiotic in laboratory medicine. Baltimore, Maryland: Williams & Wilkins; 1980. p. 265-297.
27. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker; 1982. p. 409-417.
28. Yamaoka K., Nakagawa T., Uno T. Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6:1978;547-558.
29. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames, Iowa: Iowa State University Press; 1980. p. 39-63.
30. Kaartinen L., Salonen M., Ali L., Pyorala S. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. J. Vet. Pharmacol. Ther. 18:1995;357-362.
31. Shem-Tov M., Glickman A., Saran A. Pharmacokinetics and penetration of marbofloxacin from blood into the milk of cows and ewes. J. Vet. Med. A. 44:1997;511-519.
32. Gilman AG, Goodman LS, Gilman A. Goodman and Gilman's: the pharmacological basis of therapeutics. 6th ed. New York: Macmillan Publishing Co.; 1980. p. 21, 1083.
33. Greene CE, Budsberg SC. Veterinary use of quinolones. In: Hooper DC, Wolfson JS, editors. Quinolone antimicrobial agents. 2nd ed. Washington, DC: American Society for Microbiology; 1993. p. 473-488.
34. Nix D.E., Watson W.A., Lener M.E., Frost R.W., Krol C., Goldstein H.et al. Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clin. Pharmacol. Ther. 46:1989;700-705.
35. Bapiro T.E., Andersson T.B., Otter C., Hasler J.A., Masimirembwa C.M. Cytochrome P(450) 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine primaquine and albendazole in HepG2 cells. Eur. J. Clin. Pharmacol. 58(8):2002;537-542.
36. Wise R., Lockley R., Dent J. Pharmacokinetics and tissue penetration of enoxacin. Antimicrob. Agents Chemother. 26:1984;17-19.
37. Soback S., Gips M., Bialer M., Bor A. Effect of lactation on single-dose pharmacokinetics of norfloxacin nicotinate in ewes. Antimicrob. Agents Chemother. 38:1994;2336-2339.
38. Atkinson H., Begg E. Prediction of drug distribution into human milk from physicochemical characteristics. Clin. Pharmacokinet. 218:1990;151-167.